MAPT and Alzheimer disease: To addresses some of these discrepancies between tau PET and underlying tau pathology we aimed to assess the relationship between flortaucipir uptake and tau burden in the cases of AD and 3R+4R pair helical filament tau versus those with non-AD 3R or 4R tauopathies.